Public health
American Cancer Society recommends regular prostate cancer screening
The ACS recommends PSA testing every 2 years for average-risk men ages 50 to 69, with annual screening from age 45 for higher-risk groups.
The American Cancer Society (ACS) has updated its prostate cancer screening recommendations, advising average-risk men ages 50 to 69 to have a prostate-specific antigen (PSA) test every 2 years. The Hill and MedPage Today reported the update. MedPage said the previous guidance had advised average-risk men to consult a physician before deciding whether to have a PSA test.
The ACS now recommends annual screening starting at age 45 for Black men and men with a strong family history, according to The Hill and MedPage. For men 70 to 74, it recommends individualized decisions about continuing screening. MedPage reported that screening is not recommended for men 75 and up, and that men 80 and up should not be screened.
According to MedPage, the guideline authors said the update reflects stronger evidence that PSA screening reduces prostate cancer mortality and diagnosis of late-stage disease. The guidance also recommends MRI and/or validated biomarker testing to guide biopsy decisions when elevated PSA levels are confirmed.
